High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy

被引：2
|
作者：
Mellgard, George S. [1 ]
Bhutani, Divaya [2 ]
Mapara, Markus Y. [2 ]
Maurer, Mathew S. [3 ]
Radhakrishnan, Jai [4 ]
Lentzsch, Suzanne [2 ]
Chakraborty, Rajshekhar [2 ]
机构：
[1] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA
[2] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
[3] Columbia Univ, Div Cardiol, Irving Med Ctr, New York, NY USA
[4] Columbia Univ, Div Nephrol, Irving Med Ctr, New York, NY USA
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷 / 08期
关键词：
LIGHT-CHAIN AMYLOIDOSIS; DEXAMETHASONE; INHIBITOR;
D O I：
10.1038/s41409-024-02301-7
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1181 / 1183
页数：3
相关论文
共 50 条
  • [1] HIGH-DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AL AMYLOIDOSIS PATIENTS
    Michael, M.
    Kastritis, E.
    Delimbassi, S.
    Kyrtsonis, M. C.
    Papadimetriou, C.
    Apostolides, I.
    Panayiotidis, P.
    Harhalakis, N.
    Pangalis, G.
    Dimopoulos, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 469 - 470
  • [2] High-dose melphalan followed by autologous stem cell transplantation in patients with primary systemic (AL) amyloidosis
    Knop, S
    Lengerke, C
    Hebart, H
    Kanz, L
    Einsele, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S165 - S165
  • [3] High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis
    Sanchorawala, Vaishali
    ACTA HAEMATOLOGICA, 2020, 143 (04) : 381 - 387
  • [4] High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement
    Moreau, P
    Milpied, N
    deFaucal, P
    Petit, T
    Herbouiller, P
    Bataille, R
    Harousseau, JL
    BLOOD, 1996, 87 (07) : 3063 - 3064
  • [5] Brachial Plexopathy Following High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation for AL Amyloidosis
    Vina Nguyen
    Brauneis, Dina
    Sloan, John Mark
    Sarosiek, Shayna
    Quillen, Karen
    Shelton, Anthony C.
    Sanchorawala, Vaishali
    BLOOD, 2017, 130
  • [6] Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis
    Nguyen, V. P.
    Brauneis, D.
    Kaku, M.
    Sloan, J. M.
    Sarosiek, S.
    Quillen, K.
    Shelton, A. C.
    Sanchorawala, V.
    BONE MARROW TRANSPLANTATION, 2018, 53 (03) : 371 - 373
  • [7] Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis
    V. P. Nguyen
    D. Brauneis
    M. Kaku
    J. M. Sloan
    S. Sarosiek
    K. Quillen
    A. C. Shelton
    V. Sanchorawala
    Bone Marrow Transplantation, 2018, 53 : 371 - 373
  • [8] High-dose melphalan and autologous stem cell transplantation after VAD chemotherapy for systemic light chain (AL) amyloidosis
    Perz, JB
    Schoenland, S
    Hundemer, M
    Linke, RP
    Ho, AD
    Goldschmidt, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S159 - S159
  • [9] An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis
    V Sanchorawala
    DG Wright
    DC Seldin
    LM Dember
    K Finn
    RH Falk
    J Berk
    K Quillen
    M Skinner
    Bone Marrow Transplantation, 2001, 28 : 637 - 642
  • [10] Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis
    Sanchorawala, Vaishali
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2012, 2 (01): : 9 - 17
12345